/PRNewswire/ HuidaGene Therapeutics (辉大基因; HuidaGene), a global clinical-stage biotechnology company focused on developing genomic medicine, today announced.
SHANGHAI and CLINTON, N.J., Apr. 10, 2023 /PRNewswire/ HuidaGene Therapeutics (????; HuidaGene), a global clinical-stage biotechnology company focused on developing genomic medicine, today
- Santiago Arroyo, M.D., Ph.D., appointed Chief Development Officer
- Jennifer Perry, Pharm.D., promoted to Senior Vice President, Commercial
. | April 3, 2023
Form 10-K Nuvalent, Inc. For: Dec 31 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.